Kina vs VyrarX

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Kina

Provider comparison

Women in perimenopause or menopause who want GLP-1 weight care bundled with HRT and menopause care under one named clinical lead.

Semaglutide / month: $199/moFlex Dose injection, same price at every dose, compounded; first month $169; dissolving tablet $279/mo
Tirzepatide / month: $249/moInjection, same price at every dose, compounded; first month $169; sublingual drops $229/mo

Index 70/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Kina pricing Read review

VyrarX

Provider comparison

Readers in a served state who will confirm the medication formulation, dose-specific price and refill cadence before paying.

Semaglutide / month: Formulation to confirm (semaglutide program from $179/mo)
Tirzepatide / month: Formulation to confirm (tirzepatide program from $329/mo)

Index 70/100 · Grade CChecked October 2026

Check VyrarX pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 70/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Kina: Coverage not published
VyrarX: 47 states; excludes California, South Carolina and New Jersey

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Kina

VyrarX

Semaglutide / month: Kina: $199/moFlex Dose injection, same price at every dose, compounded; first month $169; dissolving tablet $279/mo; VyrarX: Formulation to confirm (semaglutide program from $179/mo)

Tirzepatide / month: Kina: $249/moInjection, same price at every dose, compounded; first month $169; sublingual drops $229/mo; VyrarX: Formulation to confirm (tirzepatide program from $329/mo)

Semaglutide / year (modeled): Kina: $2,388; VyrarX: —

Tirzepatide / year (modeled): Kina: $2,988; VyrarX: —

State availability: Kina: Coverage not published; VyrarX: 47 states; excludes California, South Carolina and New Jersey

Oral / sublingual option listed: Kina: Yes; VyrarX: Not listed

Brand-name access listed: Kina: Not confirmed; VyrarX: Not confirmed

Provider facts checked: Kina: October 2026; VyrarX: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Kina

Women in perimenopause or menopause who want GLP-1 weight care bundled with HRT and menopause care under one named clinical lead.

Reasons to consider it

Names an actual clinical lead (Dr. Shannon Arora, PharmD) tied to a real affiliated practice with an address
LegitScript badge with a working verification link
Consultation/physician-review fee is bundled into the price rather than charged separately

What to weigh up

The $169 'starting at' price is the first month only; ongoing prices run $199 to $279 a month depending on the form
Not a dedicated GLP-1 company -- weight/GLP-1 is one of six categories on a menopause-focused platform
No named compounding pharmacy partner

Compounded drugs are not FDA-approved. Understand the medication options.

Check Kina pricing Read the full Kina review

VyrarX

Readers in a served state who will confirm the medication formulation, dose-specific price and refill cadence before paying.

Reasons to consider it

Publishes starting program rates for both molecules
Names Locum Tele as its provider network and Rush Pharmacy as its pharmacy
Lists the three excluded states in its terms

What to weigh up

The public program cards do not identify the medication as compounded or branded; confirm the exact product
Higher-dose prices, the shipment supply length and renewal cadence are not published
No individual medical director is named

Check VyrarX pricing Read the full VyrarX review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

KinaVyrarX

Normalized Cost/Month: Kina:
73/100; VyrarX:
45/100

Price Transparency: Kina:
94/100; VyrarX:
92/100

Nationwide Access: Kina:
24/100; VyrarX:
78/100

Formulation Options: Kina:
77/100; VyrarX:
66/100

Clinical Oversight: Kina:
88/100; VyrarX:
90/100

Contract Flexibility: Kina:
61/100; VyrarX:
49/100

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Kina Alternatives to VyrarX

More provider matchups

CoreAge Rx vs Kina CoreAge Rx vs VyrarX

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.